ALPS Advisors’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,508
Closed -$170K 1083
2022
Q1
$170K Sell
4,508
-523
-10% -$19.7K ﹤0.01% 812
2021
Q4
$393K Buy
+5,031
New +$393K ﹤0.01% 682